Cagent Vascular's Seed Round

Cagent Vascular raised a round of funding on November 16, 2017. Investors include Ben Franklin Technology Partners of Southeastern PA.

Cagent Vascular is a developer of technology for vessel dilatation in cardiovascular disease interventions. The Serranator is the company's first product and is an angioplasty balloon which incorpora…

Articles about Cagent Vascular's Seed Round: